Published on in Vol 8, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/34073, first published .
The Experiences of Patients With Adjuvant and Metastatic Melanoma Using Disease-Specific Social Media Communities in the Advent of Novel Therapies (Excite Project): Social Media Listening Study

The Experiences of Patients With Adjuvant and Metastatic Melanoma Using Disease-Specific Social Media Communities in the Advent of Novel Therapies (Excite Project): Social Media Listening Study

The Experiences of Patients With Adjuvant and Metastatic Melanoma Using Disease-Specific Social Media Communities in the Advent of Novel Therapies (Excite Project): Social Media Listening Study

Journals

  1. Haff P, Jacobson A, Taylor M, Schandua H, Farris D, Doan H, Nelson K. The New Media Landscape and Its Effects on Skin Cancer Diagnostics, Prognostics, and Prevention: Scoping Review. JMIR Dermatology 2024;7:e53373 View
  2. Corps K, Terry O, Lopez-Olivo M. Patient Voices in Rheumatic Immune-related Adverse Events. Rheumatic Disease Clinics of North America 2024;50(2):241 View
  3. Cimiano P, Collins B, De Vuono M, Escudier T, Gottowik J, Hartung M, Leddin M, Neupane B, Rodriguez-Esteban R, Schmidt A, Starke-Knäusel C, Voorhaar M, Wieckowski K. Patient listening on social media for patient-focused drug development: a synthesis of considerations from patients, industry and regulators. Frontiers in Medicine 2024;11 View
  4. Cai M, Li X, Luan X, Zhao P, Sun Q. Exploring m6A methylation in skin Cancer: Insights into molecular mechanisms and treatment. Cellular Signalling 2024;124:111420 View
  5. Spies E, Flynn J, Oliveira N, Karmalkar P, Gurulingappa H. Artificial intelligence–enabled social media listening to inform early patient-focused drug development: perspectives on approaches and strategies. Frontiers in Digital Health 2024;6 View